Fremanezumab- A humanized monoclonal anti-CGRP antibody-inhibits thinly myelinated (Adelta) but not unmyelinated (C) meningeal nociceptors - Melo-Carrillo, A; Strassman, AM; Nir, RR (J Neurosci, 2017)